Back to top

Truist Financial Sticks to Its Buy Rating for Tectonic Therapeutic (TECX)

Truist Financial analyst Danielle Brill maintained a Buy rating on Tectonic Therapeutic today and set a price target of $60.00. Brill covers the He...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Tectonic Therapeutic, Inc. (TECX)